Enhanced Tumour Studies (ETS)
Enhanced Tumour Studies (ETS) is a syndicated report supporting insights into prescribing and utilization patterns for Oncology markets in Canada. The reports are generated on a robust sample of patient record data which answer strategic business questions including but not limited to:
- Product and regimen share by stage and diagnosis intent
- Line of therapy
- Duration of therapy
- Demographic splits
- ECOG status
- Testing and surgery information
- Co-morbidities, etc.
The reporting provides a complete picture of the patients treatment with both oral and IV treatment represented. ETS will also include a complete picture of treatment choices in Canada including Clinical trial information. Since the sampling is distributed across Canada, a complete and accurate representation of treatment patterns are presented without bias of decisions made by regional/provincial Cancer Boards or hospitals. Analysis can be customized to your requirements to answer specific business questions.